BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

lorus therapautics Pages on BioPortfolio:

BioPortfolio - Lorus Therapeutics
Lorus Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/6519-Lorus_Therapeu...

BioPortfolio - Lorus Therapeutics - Profile
View the current Lorus Therapeutics Page on BioPortfolio.com ... Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of
cancer ...
http://www.bioportfolio.com/biocorporate/6519-Lorus+Therapeu...

BioPortfolio - Biocorporate Search immunotherapy1
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, ...
http://www.bioportfolio.com/biocorporate/immunotherapy-compa...

BioPortfolio - Lombard Life Sciences
Lombard Life Sciences · London Genetics · Long Island Life Sciences Initiative · Lonza Biologics Inc. Lonza Inc. Lorus Therapeutics Inc. . ...
http://www.bioportfolio.com/search/Lombard_Life_Sciences.htm...

Immunotherapies and Vaccines for Cancer and Infectious Diseases ...
Celldex Therapeutics Cell Genesys GenVec GlobeImmune. Lorus Therapeutics and Zor Pharmaceuticals Pharmexa 5.11. Prostate Cancer Advantagene Bavarian Nordic ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1148.html...

BioPortfolio - clinical research companies in toronto
Lorus' goal is to capitalize on its research, preclinical, clinical and ... Lorus Therapeutics Inc. is a public company listed on the Toronto Stock Exchange
...
http://www.bioportfolio.com/search/clinical_research_compani...

BioPortfolio Limited Top Companies and Products in the RNA/DNA ...
The antisense company Lorus Therapeutics is also developing an RNAi product 6.3. 12. Who is the leading RNA therapy product company? ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_325.html...

Competitive Outlook on Apoptosis in Oncology
Women's Reproductive Disorders Therapeutics 2008-2018 ... Human Genome Sciences, Introgen Therapeutics, Johnson & Johnson, Lorus Therapeutics, Madaus, ...
http://www.bioportfolio.com/cgi-bin/acatalog/copy_of_Competi...

Cancer Therapeutics Market Insight and R&D Pipeline Analysis
10.2 Lorus Therapeutics 10.21 Medarex 10.22 MedImmune 10.23 Merck & Co. 10.24 Novartis 10.25 Oncothyreon (formerly Biomira) 10.26 Pfizer 10.27 Roche ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1118.html...

Cancer Immunotherapies and Vaccines - Pipeline Analysis and ...
Oxxon Therapeutics Pfizer Progenics Pharmaceuticals Vical 4.8 Pancreatic Cancer Celldex Therapeutics Cell Genesys GenVec GlobeImmune. Lorus Therapeutics ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_593.html...

Results from other life science and pharmaceutical sites:

BioSpace - Lorus Therapeutics Inc. News, Search Jobs, Events
Lorus Therapeutics Inc. (LRP) Announces the Identification of a Potential Novel Biomarker in Patient Samples From a Clinical Trial of LOR-2040 Combined With ...
http://www.biospace.com/company_profile.aspx?CompanyId=3051...

BioPortfolio - Lorus Therapeutics
Lorus Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/6519-Lorus_Therapeu...

Lorus Therapeutics Successfully Completes Rights Offering, Raising ...
8 Aug 2008 ... 8, 2008) - Lorus Therapeutics Inc. (TSX:LOR - News; ... Lorus Therapeutics Inc.' s recent press releases are available through the Company's ...
http://biz.yahoo.com/ccn/080808/200808080478807001.html?.v=1...

Lorus Therapeutics announces reorganization resulting in ...
Newco will change its name to Lorus Therapeutics Inc. and apply for a substitutional listing of the common shares of Newco on both the Toronto Stock
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Lorus Therapeutics Announces Voluntary Delisting From the NYSE ...
Lorus Therapeutics Announces Voluntary Delisting From the NYSE Alternext. - TORONTO, ONTARIO--(MARKET WIRE)--Oct 10, 2008 -- Lorus Therapeutics Inc. ...
http://biz.yahoo.com/iw/081010/0442161.html...

GTI-2501 Lorus Therapeutics Guang-chou Tu * & Xiao Tu
Lorus Therapeutics (formerly GeneSense Technologies) is ..... 348928 Lorus Therapeutics announces anticancer drug GTI 2501. demonstrates total regression
of ...
http://www.biomedcentral.com/content/pdf/cd-424870.pdf...

Lorus Therapeutics Inc. Company Profile - Yahoo! Finance
Capsule info for Lorus Therapeutics Inc. ... Lorus Therapeutics Announces Receipt of Milestone Payment and Extension of Exclusive License Agreement for
...
http://biz.yahoo.com/ic/46/46554.html...

Lorus Therapeutics Inc. Announces Presentation Of Data From Four ...
Lorus Therapeutics Inc. is a public company listed on the Toronto Stock Exchange under the symbol LOR, and on the American Stock Exchange under the symbol ...
http://www.biospace.com/news_story.aspx?NewsEntityId=20301...

BioMed Central | Full text | GTI-2501 (Lorus Therapeutics)
1467 GTI-2501 Lorus Therapeutics Guang-chou Tu 1* & Xiao Tu 2 Addresses 1Department of Pathology, Cell Biology and Anatomy Thomas Jefferson University
...
http://www.biomedcentral.com/1472-4472/id/cd-424870/abstract...

Lorus Therapeutics Inc. Completes Reorganization Resulting in Non ...
11 Jul 2007 ... TORONTO, July 10 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. , a biopharmaceutical company specializing in the research and development ...
http://www.biospace.com/news_story.aspx?NewsEntityId=62588...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.